Navigation Links
'Triple Negative' Breast Cancers Seem to Affect the Young, Minority

Breast cancers of the “triple negative” type are destructive and lethal, and tend to strike the young, poor minority women, according to a novel// study Published in the May 1, 2007 issue of CANCER.

The study has indicated that these tumors occur commonly among women who are African American and Hispanic, below 40 years old, and who belong to the lower socioeconomic status (SES). The study also showed that triple negative tumors are linked with delayed diagnosis and shorter survival.

Tumor and tissue markers provide important information, including disease type and prognosis. Three important markers in breast cancer are estrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), and progesterone receptor (PR). In particular, these markers are useful in selecting appropriate adjuvant therapy and prognosis. Around 15 percent of breast cancers do not express any of these markers and are generally identified as basal-like subtypes. While these “triple negative” tumors are associated with poor prognosis and survival, hormone adjuvant therapy failure, and are often identified in African American women, little is understood about other associated demographic risk factors.

Katrina Bauer from the Public Health Institute in Sacramento, California and colleagues compared the demographic, clinical and survival characteristics of 6,370 women diagnosed with triple negative breast cancers with 44,704 women with other breast cancers.

The authors found that race and age, in particular, as well as socioeconomic status were risk factors for this type of breast cancer. Compared to Caucasians, African American women were at greatest risk followed by Hispanic women. Women under 40 years old were at greater risk than women over 60 years old. Women living in lower SES were also at higher risk compared to the highest SES.

Clinically, these tumors were more aggressive, diagnosed at more advanced stages. They were also a ssociated with shorter survival, regardless of stage at diagnosis. African American women had the poorest five-year survival, with only 14 percent alive five years after diagnosis.

From these results, Ms. Bauer and co-authors conclude that “age less than 40 years, being non-Hispanic black and, to a lesser extent, being Hispanic, are clearly the most powerful risk factors for this poor prognosis subtype of breast cancer.”

Source-EurekalertSAV
'"/>




Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/16/2017)... ... 16, 2017 , ... Date aired: January 9, 2017 , ... Kleyne, America’s leading water educator, researcher and advocate welcomed health activist, author, science ... Kleyne Hour Power of Water, Global Climate Change and Your Health on Voice ...
(Date:1/16/2017)... , ... January 16, 2017 , ... One thing common ... to treat, but to test for, as well. The money spent screening for and ... Doctors in the U.S. screen patients for cancer more than in any other country ...
(Date:1/16/2017)... WA (PRWEB) , ... January 16, 2017 , ... NexTec ... 2016, a group of 100 organizations honored for their accomplishments in the field of ... such growth, industry leadership and recognition, and innovation. Selection is not based on revenue ...
(Date:1/15/2017)... , ... January 15, 2017 , ... Whole Health Supply, LLC is announcing the release ... are also new avenues for purchase. , The 2017 edition has wide jaws that ... for the older boomers as well as diabetics. This handle is reinforced for extra strength ...
(Date:1/15/2017)... ... January 15, 2017 , ... ... physicians in eight Bay Area counties for 2017. Almost 1,000 nominations were submitted ... managing the award process. Results were announced the magazine’s January 2017 issue ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... January 13, 2017 Constant research ongoing ... will collectively contribute to the demand for western blotting technique. ... value of US$ 551.0 Mn by 2016 end. Developing economies ... most lucrative markets for western blotting, whereas North ... ...
(Date:1/13/2017)... MURRIETA, Calif. , Jan. 13, 2017  Alfalfa, cattle, ... COPAN Diagnostic,s new environmental sampling film , which emphasizes the ... video, released today, highlights how COPAN,s ... product that simplifies the surface sampling process in the wake ... . In addition, COPAN is expanding ...
(Date:1/13/2017)... -- This morning, Stock-Callers.com draws attention to ... at yesterday,s closing bell: Clovis Oncology Inc. (NASDAQ: ... GALE ), and ACADIA Pharmaceuticals Inc. (NASDAQ: ... to develop technologies and products that combat debilitating and ... use less and cleaner energy, and provide safer, cleaner ...
Breaking Medicine Technology: